Trial intelligence / Profile preview

Ritonavir-boosted Lopinavir Monotherapy vs Combination in HIV

NCT01189695Phase 4Completed

Sponsor
Bamrasnaradura Infectious Diseases Institute
Start
Dec 2010
Primary completion
Dec 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of lopinavir, ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Bamrasnaradura Infectious Diseases Institute. Started Dec 2010; status: completed.

02

Drugs

lopinavirritonavir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01189695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01189695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call